Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer

Clinical trial NCT05737303 · RECRUITING

Trial details

NCT number: NCT05737303
Sponsor: Women's Hospital School Of Medicine Zhejiang University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Epithelial Ovarian Carcinoma Stage III Epithelial Ovarian Carcinoma Stage IV Fallopian Tube Carcinoma Stage III Fallopian Tube Carcinoma Stage IV Primary Peritoneal Carcinoma Stage III Primary Peritoneal Carcinoma Stage IV

Start date: 2023-11-27
Primary completion: 2025-12-31
Enrollment: 538

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.